BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15258589)

  • 1. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation.
    Chadee DN; Kyriakis JM
    Nat Cell Biol; 2004 Aug; 6(8):770-6. PubMed ID: 15258589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for mixed lineage kinase 3 (MLK3) in B-Raf activation and cell proliferation.
    Chadee DN; Kyriakis JM
    Cell Cycle; 2004 Oct; 3(10):1227-9. PubMed ID: 15467451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
    Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA
    Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.
    Chadee DN; Xu D; Hung G; Andalibi A; Lim DJ; Luo Z; Gutmann DH; Kyriakis JM
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4463-8. PubMed ID: 16537381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf.
    Mercer K; Chiloeches A; Hüser M; Kiernan M; Marais R; Pritchard C
    Oncogene; 2002 Jan; 21(3):347-55. PubMed ID: 11821947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAF protein-serine/threonine kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
    Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
    Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic modulation of Ca2+ -activated K+ channels in proliferating A7r5 vascular smooth muscle cells.
    Si H; Grgic I; Heyken WT; Maier T; Hoyer J; Reusch HP; Köhler R
    Br J Pharmacol; 2006 Aug; 148(7):909-17. PubMed ID: 16770324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
    Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
    J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
    Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
    J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.
    Mason CS; Springer CJ; Cooper RG; Superti-Furga G; Marshall CJ; Marais R
    EMBO J; 1999 Apr; 18(8):2137-48. PubMed ID: 10205168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
    Repasky GA; Zhou Y; Morita S; Der CJ
    Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen type I-mediated activation of ERK/MAP Kinase is dependent on Ras, Raf-1 and protein phosphatase 2A in Jurkat T cells.
    Chetoui N; Gendron S; Chamoux E; Aoudjit F
    Mol Immunol; 2006 Apr; 43(10):1687-93. PubMed ID: 16266749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.